Fundraising September 15, 2024 – October 1, 2024 About fundraising

VANTAGE 095: An International, Multicenter, Open-Label...

  • Main
  • 2016 / 3
  • VANTAGE 095: An International, Multicenter, Open-Label...

VANTAGE 095: An International, Multicenter, Open-Label Study of Vorinostat (MK-0683) in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma

Siegel, David S., Dimopoulos, Meletios, Jagannath, Sundar, Goldschmidt, Hartmut, Durrant, Simon, Kaufman, Jonathan L., Leleu, Xavier, Nagler, Arnon, Offner, Fritz, Graef, Thorsten, Eid, Joseph E., Hou
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2016.02.042
Date:
March, 2016
File:
PDF, 1.27 MB
english, 2016
Conversion to is in progress
Conversion to is failed